DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

Novartis (NYSE: NVS)

company name or ticker
Company Photos
(Click to zoom)

Before the Move: Watch Cellectis Into UCART19 Data

Novartis Is Struggling To Compete

Stocks Rise; HP Inc. Jumps After Hewlett-Packard Split

Which Of The Latest 13F Filers Holds Novartis?

Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for November 03, 2015

Guru Stocks at 52-Week Lows: NVS, WMT, IBM, AXP, CHU

5 Healthcare Trends to Invest in for the Next 20 Years

Our contributors think that healthcare-focused investors should watch these 5 long-term healthcare trends.

Generic Copaxone Isn't Derailing Teva Pharmaceuticals...Yet

Revenue from Copaxone has yet to fall dramatically following this year's approval of a generic version of the widely used MS therapy.

Teva's Q3 Earnings & Revenues Top Expectations, View Up

GlaxoSmithKline's Diverging Q3 Results Imply a Long Road to Recovery

GlaxoSmithKline's third-quarter results topped estimates, but the pharmaceutical giant is still facing quite the uphill battle.
See More Articles...